This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
News & Press: ISPAD COVID-19 Section

The Global Covidiab Registry

Monday, August 31, 2020   (0 Comments)

The Global Covidiab Registry - new-onset diabetes, and the Covid-19 Pandemic

In early 2020, there were sporadic reports on new-onset diabetes, both type 1 and type 2, in both children and adults with SARS-CoV-2 (COVID-19) infection. To date, all studies on the subject have been limited by small sample sizes and the fact a diagnosis of COVID-19 could not always be confirmed. In order to address these limitations, an International group of leading diabetes researchers set up a global registry of Covid-19–related diabetes, Its aim is to establish the extent, natural history and longer term outcomes of new-onset diabetes in the context of the pandemic. Read more about the Global Covidiab Registry here.

Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal